ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø

ÀÇ·áÁø »çÁø
¼ÛÁøÈ­ ±³¼ö
Áø·á°ú È£Èí±â-¾Ë·¹¸£±â³»°ú HOME

Àü¹®Áø·áºÐ¾ß

¸¸¼ºÆó¼â¼ºÆóÁúȯ, ¸¸¼º±âµµÁúȯ, °£Áú¼º ÆóÁúȯ, ¹× È£Èí±â Áúȯ

ÀüÈ­ ¿¹¾à 1522-2500

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2025-03-31 ~ 2025-04-05)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·á¿Ü·¡Áø·á
¿ÀÈÄ ¿Ü·¡Áø·á

ÇзÂ

ÇзÂ

2013¼­¿ï´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø Á¹¾÷

2021¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇÐ ¹Ú»ç

°æ·Â

°æ·Â

2013 ~ 2014¼­¿ï´ëÇб³º´¿ø ÀÎÅÏ

2014 ~ 2018¼­¿ï´ëÇб³º´¿ø ³»°ú Àü°øÀÇ

2018 ~ 2019¼­¿ï´ëÇб³º´¿ø È£Èí±â³»°ú ÀüÀÓÀÇ

2019 ~ 2025Áß¾Óº¸Èƺ´¿ø È£Èí±â³»°ú Àü¹®ÀÇ

2025 ~ ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ÀÓ»óÁ¶±³¼ö

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇÑ°áÇÙÈ£Èí±âÇÐȸ

´ëÇÑÆó¾ÏÇÐȸ

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

APSR Assembly Education Award (2024)

³í¹®/Àú¼­

³í¹®/Àú¼­
1. Beyond the Spirometry: New Diagnostic Modalities in COPD Tuberc Respir Dis (Seoul). 2024 Sep 23

2. Clinical Impacts of Pseudomonas aeruginosa Isolation in Patients with Bronchiectasis: Findings from KMBARC Registry J Clin Med. 2024 Aug 24;13(17):5011.

3. Impact of body mass index on development of nontuberculous mycobacterial pulmonary disease. Eur Respir J. 2021 Feb 4;57(2):2000454.

4. Evolution of Interferon-Gamma Release Assay Results and Submillisievert Chest CT Findings among Close Contacts of Active Pulmonary Tuberculosis Patients. Tuberc Respir Dis (Seoul). 2020 Oct;83(4):283-288.

5. The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study. Respir Res. 2019 Dec 16;20(1):283.

6. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis. PLoS One. 2019 Sep 19;14(9):e0222810.

7. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis. PLoS One. 2019 Sep 19;14(9):e0222810.

8. Prognostic Implication of Adrenocortical Response during the Course of Critical Illness. Acute Crit Care. 2019 Feb;34(1):38-45

9. Effect of intensivist involvement on clinical outcomes in patients with advanced lung cancer admitted to the intensive care unit. PLoS One. 2019 Feb 13;14(2):e0210951.

10. Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts. Int J Chron Obstruct Pulmon Dis. 2018 Oct 23;13:3473-3484.

11. Differences in prevalence of asthma-COPD overlap according to different criteria. Medicine (Baltimore). 2018 Sep;97(36):e12049

12. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD. Int J Chron Obstruct Pulmon Dis. 2017 Aug 17;12:2455-2464.